GenScript gets FDA EUA for use of cPass Covid-19 test in convalescent plasma screening
The cPass kit has the potential to detect Covid-19 neutralising antibodies without the use of live virus
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
12 Feb 21
The cPass kit has the potential to detect Covid-19 neutralising antibodies without the use of live virus
12 Feb 21
The AI-powered electromagnetic field therapy is designed to minimise disability after neurological damage caused by stroke
12 Feb 21
Indicated for the treatment of intracranial aneurysms, the Contour Neurovascular System™, composed of fine mesh braid, represents a…
11 Feb 21
The medical watch enables continuous measurement of heart rate and arrhythmias
09 Feb 21
The assay uses the sandwich test format for the detection of GDF-15 in human serum
09 Feb 21
The FDA Breakthrough Device Program is intended to help patients receive more timely access to breakthrough technologies that…
08 Feb 21
The eXciteOSA device delivers neuromuscular stimulation to the tongue to reduce snoring and mild sleep apnea
08 Feb 21
B-Secur’s HeartKey is a suite of EKG/ECG algorithms that uniquely combine user identification, health and wellness to generate…
05 Feb 21
The system is designed for use in skeletally mature patients with degenerative disc disease of the cervical spine…
04 Feb 21
The CellFX system is approved for dermatologic procedures, which need ablation and resurfacing of the skin